| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GW-2580 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K13185470 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.6 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |